Celestica Inc

CLS remains in a Stage 4 decline with active support failures and a bearish medium-term bias. Price is currently rallying into the declining 9/21 EMAs and 50 DMA resistance after an extreme oversold bottom, presenting a favorable sell setup. We will sell now at the EMAs and 50 DMA resistance zone, seeking rejection and continuation of the downtrend.

• ↑Q1 2026 revenue $4.05 B (+53% YoY) driven by hyperscaler orders.
• ↑Adjusted operating margin expanded to 8% in Q1, reflecting disciplined capital allocation.
• ↓Valuation premium and weak earnings yield suggest overvaluation risk.